8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.
1981 / Observational study
The relation between frequency of bowel movements and epithelial dysplasia in nipple aspirates of breast fluid was examined in 1481 white women. Women reporting severe constipation (two or fewer bowel movements weekly) had a significant positive association with dysplasia (risk ratio 4.5; 95% confidence interval 1.9-11.9), which was not observed in women with more than one bowel movement daily. Increased risk ratios were also observed in women who had one bowel movement daily or one every other day.
Shows an association, not proof of cause and effect.
Petrakis NL, King EB Lancet, 1981. PMID 6118633
1981 / Comparative observational study
Bowel transit time was examined in vegetarians and non-vegetarians and related to dietary fibre intake and diverticular disease. Vegetarians, who have less diverticular disease than non-vegetarians, had more rapid transit times. Participants with a total dietary fibre intake above 30 g/d all had transit times below 75 h, compared to 38% of those consuming less fibre whose transit times exceeded 75 h (up to 124 h). Individuals with diverticular disease demonstrated faster transit times than those without the disease.
Shows an association, not proof of cause and effect.
Gear JS, Brodribb AJ, Ware A, et al. Br J Nutr, 1981. PMID 6258626
1981 / Observational study
Researchers examined the effects of dietary fiber and personality factors on stool output. Total neutral detergent fiber was predictive of stool weight but not stool frequency. Substantial individual differences in stool output remained after controlling for dietary factors. Personality measures predicted stool weight and frequency independently of diet, accounting for about as much variance in stool output as dietary fiber.
Shows an association, not proof of cause and effect.
Tucker DM, Sandstead HH, Logan GM, et al. Gastroenterology, 1981. PMID 6269944
1980 / Methodological and controlled-diet metabolic study
A method was developed to fractionate human faeces into microflora, dietary-fibre residues, and water-soluble material. In nine healthy subjects consuming a metabolically controlled British-type diet, bacteria accounted for 54.7 +/- 1.7% of total solids, fibre accounted for 16.7 +/- 0.8%, and soluble material accounted for 24.0 +/- 1.3%. The microbial fraction contained 95% of total bacteria, had 6% nitrogen, and accounted for 60% of total faecal nitrogen, indicating bacteria represent a much larger proportion of faecal mass than previously thought.
Shows an association, not proof of cause and effect.
Stephen AM, Cummings JH J Med Microbiol, 1980. PMID 7359576
1979 / Case series
Between 1967 and 1977, fasting therapy was administered to approximately 382 patients with psychosomatic diseases in a Japanese clinic. The therapy achieved a reported efficacy rate of 87%. Suitable indications included irritable colon, eating behavioral disturbances, functional gastrointestinal disorders, neurocirculatory asthenia, labile hypertension, puberty-related psychosomatic symptoms, conversion hysteria, and neuroses with somatic complaints.
Shows an association, not proof of cause and effect.
Suzuki J, Yamauchi Y, Yamamoto H, et al. Psychother Psychosom, 1979. PMID 482552
1979 / Cross-sectional comparative study
A study evaluated the relationship between symptomless diverticular disease of the colon and dietary fibre consumption in vegetarians and non-vegetarians. Vegetarians had a significantly higher mean fibre intake (41.5 g/day) compared to non-vegetarians (21.4 g/day). Diverticular disease was found in 33% of non-vegetarians compared with 12% of vegetarians. Comparisons between participants with and without the condition provided further evidence that a low intake of cereal fibre is associated with the presence of diverticular disease.
Shows an association, not proof of cause and effect.
Gear JS, Ware A, Fursdon P, et al. Lancet, 1979. PMID 85104
1979 / Ecological study
Using food disappearance data from 1954-65 and mortality data from 1967-73 across 20 industrialised countries, researchers examined independent relationships between diet variables and colon cancer. Simple correlation analysis showed total fat, saturated fat, monounsaturated fat, cholesterol, and fibre intakes were each highly correlated with colon-cancer mortality. The partial correlation of dietary cholesterol with colon cancer remained highly significant when controlling for fat or fibre, whereas correlations for fat or fibre were no longer significant when cholesterol was controlled. Cross-classification showed a highly significant main effect for cholesterol, but not for fat or fibre.
Shows an association, not proof of cause and effect.
Liu K, Stamler J, Moss D, et al. Lancet, 1979. PMID 90870
1977 / Cross-sectional comparative study
1259 Tanzanians in a provincial town were examined for varicose veins. Among 1000 people aged 18 years and over, 5.5% (6.1% of men and 5.0% of women) had varicose veins, which is intermediate between rates reported for minimally developed areas (0.1%-0.4%) and Michigan (12.3%). The diet included some refined carbohydrate, and the mean daily stool weight was 228 g, falling between traditional African communities (490 g) and Western countries (115 g). These findings are consistent with the hypothesis relating varicosities to a fiber-depleted diet, while life-long use of the squatting position for defecation did not protect against varicose veins.
Shows an association, not proof of cause and effect.
Richardson JB, Dixon M Lancet, 1977. PMID 66583
1973 / Correlation study
The study examined the correlation between cancers of the breast, colon, and stomach, dietary factors, and various indicators of standard of living. Cancer of the breast and colon was found to be highly correlated with fat and animal protein.
Shows an association, not proof of cause and effect.
Drasar BS, Irving D Br J Cancer, 1973. PMID 4694388
1969 / Ecological correlation study
This study evaluated the hypothesis of a relationship between gastrointestinal cancer mortality and living standards using correlation analysis. An inverse relationship was observed between gastric and intestinal cancer mortality rates (r = -0.85). Higher food intake, measured as animal protein intake, correlated with lower gastric cancer mortality but higher intestinal cancer mortality. The authors noted that these correlation findings do not demonstrate causality or a direct effect on gastrointestinal cancer, and that no time lag was proven between food intake and intestinal cancer mortality.
Shows an association, not proof of cause and effect.
Gregor O, Toman R, Prusová F Gut, 1969. PMID 5366239
2024 / Narrative review
This review summarizes mechanisms by which dietary fibers influence appetite regulation and body weight. Fibers act through gastric distention, delayed gastric emptying, prevention of hypoglycemia, ileal nutrient delivery, and short-chain fatty acid stimulation of hormones like CCK, GLP-1, and PYY. Randomized controlled trials report reduced energy intake, reduced hunger, increased satiety, and lower body weight, which are supported by cohort studies. However, the extent of weight loss has been small in some studies, and controversies remain regarding fiber's effects on gastrointestinal hormones and weight loss.
Akhlaghi M Crit Rev Food Sci Nutr, 2024. PMID 36193993
2024 / Narrative review
This review summarizes human studies evaluating how soluble cereal fiber affects glycometabolic gastrointestinal hormones. In intervention studies, soluble fibers elicit short-term anti-hyperglycemic and anti-inflammatory effects, and beta-glucans lower cholesterol and may reduce liver fat, but long-term benefits remain unproven. Effects on GLP-1 appear highly contradictory, whereas soluble fibers might lower GIP and ghrelin and increase PYY and CCK. The authors note that larger acute and long-term mechanistic studies are required to corroborate these findings.
Kabisch S, Weickert MO, Pfeiffer AFH Crit Rev Food Sci Nutr, 2024. PMID 36382636
2024 / Narrative review
This review discusses dietary fiber as a key dietary constituent with established mechanisms of action and health effects. It notes that several aspects still require exploration, such as the contribution of cell-wall-linked phenolic compounds and the relevance of the gut-brain axis. Furthermore, increasing dietary fiber intake remains a major public health challenge because global intakes fall well below recommendations.
Pérez-Jiménez J Food Chem, 2024. PMID 38039615
2024 / Narrative review
This review describes alpha-gal syndrome (AGS), an allergic disorder mediated by IgE antibodies against galactose-alpha-1,3-galactose following tick bites. Ingestion of mammalian meat, visceral organs, dairy, gelatin, or mammal-derived medications can trigger delayed allergic reactions, typically occurring 2 to 6 hours post-consumption. Manifestations range from urticaria and anaphylaxis to isolated gastrointestinal symptoms, and alpha-gal sensitization has also been linked with cardiovascular disease.
Wilson JM, Erickson L, Levin M, et al. Allergy, 2024. PMID 38193233
2024 / Narrative review
This review summarizes recent research on how gut hormones interact with the brain to influence appetite and body weight. Ghrelin acts as an orexigenic hormone, while GLP-1, GIP, CCK, PYY, and OXM act as anorexigenic hormones, with actions extending into systems such as adipose tissue and high-order thinking. Environmental factors, including meal schedule, food contents and quality, exercise type, and sleep deprivation, influence these gut hormone pathways. Additionally, studies show that retatrutide (a triple-agonist of GLP-1, GIP, and glucagon receptor) and orforglipron (a GLP-1 receptor partial agonist) promote weight loss and improve metabolic parameters associated with obesity.
Hong SH, Choi KM Curr Opin Endocrinol Diabetes Obes, 2024. PMID 38511400
2024 / Narrative review
This review examines the relationships between incretin hormones, gut microbiota, and obesity. Gastrointestinal incretins such as GIP and GLP-1 are secreted following nutrient intake and impact lipid metabolism, gastric emptying, appetite, and body weight. The gut microbiota influences host metabolism by modulating incretin secretion via enteroendocrine cells, with microbial metabolites like short-chain fatty acids and indole directly stimulating incretin release. Additionally, incretin-based therapies and bariatric surgery are associated with increases in gut bacterial richness and diversity.
Angelini G, Russo S, Mingrone G Peptides, 2024. PMID 38636809
2024 / Narrative literature review
This narrative review examined best practices for diagnosing and treating vitamin B12 deficiency. Reduced dietary intake requires oral supplementation, whereas parenteral (intramuscular) therapy is preferred for malabsorption because oral supplementation is likely insufficient. Clinical and patient experience suggests up to 50% of individuals require individualized injection regimens ranging from daily or twice weekly to every 2-4 weeks to stay symptom-free. The authors note there is no evidence that oral or sublingual supplementation can safely replace injections in malabsorption, and titrating injection frequency using biomarkers like serum B12 or MMA should not be practiced.
Wolffenbuttel BHR, McCaddon A, Ahmadi KR, et al. Food Nutr Bull, 2024. PMID 38987879
2024 / Narrative review
This review examines how sulfidogenic members of the human gut microbiota contribute to disease pathogenesis. Diets high in animal protein, fat, and sugar in Western countries are implicated in the overgrowth of sulfide-producing bacteria, such as Desulfovibrio spp. and Bilophila wadsworthia. These bacteria convert sulfur compounds to sulfide, which at high concentrations is cytotoxic, disrupts the intestinal epithelium and mucus barrier, and triggers inflammation. The authors discuss the pathogenic potential of these microbes and their links to inflammatory bowel diseases, colorectal cancer, and other disorders.
Shows an association, not proof of cause and effect.
Pimenta AI, Bernardino RM, Pereira IAC Adv Microb Physiol, 2024. PMID 39059820
2023 / Scoping review of clinical trials
A scoping review evaluated 389 citations from human clinical trials investigating the effects of oral curcumin on disease outcomes. Nearly half the citations focused on obesity-associated metabolic disorders (29%) or musculoskeletal disorders (17%), with beneficial effects on clinical outcomes and/or biomarkers reported in 75% of these studies (77% of which were double-blind randomized placebo-controlled trials). Trials on neurocognitive (11%), gastrointestinal (10%), or cancer (9%) categories were fewer and reported mixed results depending on study quality and condition. The authors noted the need for systematic evaluation of diverse formulations and doses in larger trials.
Panknin TM, Howe CL, Hauer M, et al. Int J Mol Sci, 2023. PMID 36901908
2023 / Narrative review of author studies and literature
This review describes the rationale for using a plant-based diet (PBD, specifically a lacto-ovo-vegetarian diet) in inflammatory bowel disease (IBD) and reviews the authors' modality in Japan. Infliximab and PBD as first-line therapy for newly developed Crohn's disease (CD) achieved a 96% remission rate and yielded a relapse-free course in 52% of patients. The authors assert that IBD is linked to dietary westernization and recommend PBD as part of IBD therapy.
Chiba M, Morita N Metabolites, 2023. PMID 36984772
2023 / Narrative review
This review examines semaglutide, approved for type 2 diabetes and obesity management. Manufacturer-sponsored randomized controlled trials showed a loss of almost 12% of body weight over 68 weeks, though individuals regain most of their pretreatment weight once medication is stopped. Gastrointestinal adverse events occur commonly, and pancreatitis, diabetic retinopathy, and severe allergic reactions have also been reported.
Lexchin J, Mintzes B Drug Ther Bull, 2023. PMID 37879878
2023 / Narrative review with clinical case series data
The authors review dietary factors in inflammatory bowel disease and describe outcomes incorporating a lacto-ovo-semi-vegetarian plant-based diet (PBD) into inpatient and post-discharge practice. First-line therapy with infliximab and PBD achieved a remission rate of 96% (44/46) in Crohn's disease (CD) and 76% (13/17) in severe ulcerative colitis (UC). In CD, a relapse-free outcome was achieved in 52% of patients at 10-year follow-up without biologics or immunosuppressants, while cumulative relapse rates for 51 initial episode UC cases at 1 and 5 years were 14% and 27%, respectively. Additionally, PBD alone induced remission without medication in approximately one-third of mild UC cases.
Chiba M, Tsuji T, Komatsu M Transl Gastroenterol Hepatol, 2023. PMID 38021365
2022 / Narrative review
This review summarizes recent findings regarding the effects of apoE on intestinal function in health and disease. It highlights the role of the APOE4 polymorphism in protecting against infection and malnutrition in children residing in unfavorable settings with poor sanitation and hygiene. The authors also discuss the potential impact of APOE4 on later development and outline knowledge gaps concerning children's development under adverse conditions.
Shows an association, not proof of cause and effect.
Freitas RS, Roque CR, Matos GA, et al. Nutr Rev, 2022. PMID 34406390
2022 / Narrative review
This review examines the physiological functions of GLP-1 and its development into pharmaceuticals for obesity and type 2 diabetes (T2DM). GLP-1 receptor agonists are highlighted as effective anti-obesity agents and recommended second-line therapies for T2DM, particularly for patients with increased cardiovascular risk. The author discusses proglucagon processing across tissues and notes that the relationship between endogenous GLP-1 actions and the clinical effects of agonists is far from congruent and generally poorly understood.
Holst JJ J Intern Med, 2022. PMID 34982496